Search Results

There are 5336 results for: content related to: Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

  1. Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 313–322, Myoung Ha Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Eun Hee Choi, Kwang Hun Lee, Do Yun Lee, Jinsil Seong, Kwang-Hyub Han, Chae Yoon Chon and Jun Yong Park

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06867.x

  2. You have free access to this content
    α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 3, August 2005, Pages: 217–226, L.-T. CHEN, T.-W. LIU, Y. CHAO, H.-S. SHIAH, J.-Y. CHANG, S.-H. JUANG, S.-C. CHEN, T.-R. CHUANG, Y.-H. CHIN and J. WHANG-PENG

    Version of Record online : 21 JUL 2005, DOI: 10.1111/j.1365-2036.2005.02547.x

  3. Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 369–376, Beom Kyung Kim, Sang Hoon Ahn, Jin Sil Seong, Jun Yong Park, Do Young Kim, Ja Kyung Kim, Do Youn Lee, Kwang Hoon Lee and Kwang-Hyub Han

    Version of Record online : 17 NOV 2010, DOI: 10.1111/j.1478-3231.2010.02368.x

  4. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  5. You have full text access to this OnlineOpen article
    Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma

    Cancer

    Volume 120, Issue 2, 15 January 2014, Pages: 229–237, Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, Masaru Muraoka, Toru Nakata, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Takashi Nishimura, Ken Ueda, Teiji Kuzuya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto and Namiki Izumi

    Version of Record online : 7 OCT 2013, DOI: 10.1002/cncr.28384

  6. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 313–321, Hana Park, Seung Up Kim, Jun Young Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han and Jinsil Seong

    Version of Record online : 29 JUL 2013, DOI: 10.1111/liv.12274

  7. You have free access to this content
    Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1068–1077, Austin Duffy, Julia Wilkerson and Tim F. Greten

    Version of Record online : 18 JAN 2013, DOI: 10.1002/hep.26120

  8. You have free access to this content
    A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma

    Cancer

    Volume 121, Issue 10, May 15, 2015, Pages: 1620–1627, Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Alex Aspinall, Kelly W. Burak, Neesha Dhani, Eric Chen, Mehrdad Sinaei, Glen Lo, Tae Kyoung Kim, Patrik Rogalla, Oliver F. Bathe and Jennifer J. Knox

    Version of Record online : 6 JAN 2015, DOI: 10.1002/cncr.29227

  9. Recent topics on α-fetoprotein

    Hepatology Research

    Volume 43, Issue 8, August 2013, Pages: 820–825, Kazuhiko Nakao and Tatsuki Ichikawa

    Version of Record online : 25 JAN 2013, DOI: 10.1111/hepr.12052

  10. You have free access to this content
    The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2261–2273, Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner and Markus Peck-Radosavljevic

    Version of Record online : 3 MAY 2013, DOI: 10.1002/hep.26256

  11. You have free access to this content
    Treating advanced hepatocellular carcinoma: How to get out of first gear

    Cancer

    Volume 120, Issue 20, October 15, 2014, Pages: 3122–3130, James J. Harding and Ghassan K. Abou-Alfa

    Version of Record online : 4 JUN 2014, DOI: 10.1002/cncr.28850

  12. You have free access to this content
    Antiangiogenic therapy for high-grade glioma

    Intervention Review

    The Cochrane Library

    Mustafa Khasraw, Malaka S Ameratunga, Robin Grant, Helen Wheeler and Nick Pavlakis

    Published Online : 22 SEP 2014, DOI: 10.1002/14651858.CD008218.pub3

  13. You have free access to this content
    Poster Presentations

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S3, October 2013, Pages: 23–693,

    Version of Record online : 17 SEP 2013, DOI: 10.1111/jgh.12363_2

  14. Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 7, July 2015, Pages: 1175–1182, Sung Wook Yang, Gi Hyun Kim, Jung Wha Chung, Hyung Rae Sohn, Sang Soo Lee, Sukho Hong, Seong Min Chung, Eun Sun Jang, Sook-Hyang Jeong and Jin-Wook Kim

    Version of Record online : 10 JUN 2015, DOI: 10.1111/jgh.12921

  15. Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma

    Hepatology Research

    Seiji Tsunematsu, Goki Suda, Kazushi Yamasaki, Megumi Kimura, Izumi Takaaki, Machiko Umemura, Jun Ito, Fumiyuki Sato, Masato Nakai, Takuya Sho, Kenichi Morikawa, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi and Naoya Sakamoto

    Version of Record online : 11 AUG 2016, DOI: 10.1111/hepr.12775

  16. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1463–1469, Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Soo Young Park, Ja Kyung Kim, Hyun Woong Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Young Oh Kweon, Jung Il Lee, Kwan Sik Lee, Hyung Joon Kim and Kwang-Hyub Han

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12542

  17. You have free access to this content
    A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 124–132, Daniel H. Palmer, Rachel S. Midgley, Noweeda Mirza, Elizabeth E. Torr, Forhad Ahmed, Jane C. Steele, Neil M. Steven, David J. Kerr, Lawrence S. Young and David H. Adams

    Version of Record online : 3 NOV 2008, DOI: 10.1002/hep.22626

  18. Antiangiogenic Therapy for Cancer: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1095–1111, Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L. DeRemer and Payaningal R. Somanath

    Version of Record online : 3 DEC 2012, DOI: 10.1002/phar.1147

  19. You have full text access to this OnlineOpen article
    Clinical Trial Simulations From a Model-Based Meta-Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 5, Issue 5, May 2016, Pages: 274–282, ML Zierhut, Y Chen, YK Pithavala, DJ Nickens, O Valota and MA Amantea

    Version of Record online : 15 MAY 2016, DOI: 10.1002/psp4.12078

  20. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy

    Liver International

    Volume 33, Issue 9, October 2013, Pages: 1413–1419, Yu-Yun Shao, Po-Chin Liang, Yao-Ming Wu, Chun-Chieh Huang, Kai-Wen Huang, Jason C. Cheng, Chih-Hung Hsu, Chiun Hsu, Ann-Lii Cheng and Zhong-Zhe Lin

    Version of Record online : 28 MAY 2013, DOI: 10.1111/liv.12207